124 related articles for article (PubMed ID: 19199272)
1. Detection of cytokeratin 19 mRNA and CYFRA 21-1 (cytokeratin 19 fragments) in blood of Tunisian women with breast cancer.
Marrakchi R; Ouerhani S; Benammar S; Rouissi K; Bouhaha R; Bougatef K; Messai Y; Khadimallah I; Rahal K; Ben Ammar-Elgaaied A
Int J Biol Markers; 2008; 23(4):238-43. PubMed ID: 19199272
[TBL] [Abstract][Full Text] [Related]
2. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
3. Circulating cytokeratin 19 fragments in patients with benign nodules and carcinomas of the thyroid gland.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M
Int J Biol Markers; 2008; 23(1):54-7. PubMed ID: 18409152
[TBL] [Abstract][Full Text] [Related]
4. Non-coding CK19 RNA in peripheral blood and tissue of breast cancer patients.
Oloomi M; Yardehnavi N; Bouzari S; Moazzezy N
Acta Med Iran; 2013 Mar; 51(2):75-86. PubMed ID: 23585313
[TBL] [Abstract][Full Text] [Related]
5. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
Zheng HY; Chen Q; Ye YB; Huang WW
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
[TBL] [Abstract][Full Text] [Related]
6. Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
Schröder CP; Ruiters MHJ; de Jong S; Tiebosch ATMG; Wesseling J; Veenstra R; de Vries J; Hoekstra HJ; de Leij LFMH; de Vries EGE
Int J Cancer; 2003 Sep; 106(4):611-618. PubMed ID: 12845661
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
8. Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients.
Li Y; Tang ZY; Tian B; Ye SL; Qin LX; Xue Q; Sun RX
J Cancer Res Clin Oncol; 2006 Aug; 132(8):515-20. PubMed ID: 16788845
[TBL] [Abstract][Full Text] [Related]
9. RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters.
Kahn HJ; Yang LY; Blondal J; Lickley L; Holloway C; Hanna W; Narod S; McCready DR; Seth A; Marks A
Breast Cancer Res Treat; 2000 Mar; 60(2):143-51. PubMed ID: 10845277
[TBL] [Abstract][Full Text] [Related]
10. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
11. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
[TBL] [Abstract][Full Text] [Related]
12. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer.
Visser M; Jiwa M; Horstman A; Brink AA; Pol RP; van Diest P; Snijders PJ; Meijer CJ
Int J Cancer; 2008 Jun; 122(11):2562-7. PubMed ID: 18324628
[TBL] [Abstract][Full Text] [Related]
13. Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma.
Nakata B; Ogawa Y; Ishikawa T; Ikeda K; Kato Y; Nishino H; Hirakawa K
Cancer; 2000 Sep; 89(6):1285-90. PubMed ID: 11002224
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
[TBL] [Abstract][Full Text] [Related]
15. [Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].
López Guerrero JA; Bolufer P; Barragán E; Sanz Alonso M; Palau J; Sempere A; De la Rubia J; Bonanad S; Torregrosa MD
Sangre (Barc); 1996 Dec; 41(6):441-6. PubMed ID: 9148421
[TBL] [Abstract][Full Text] [Related]
16. The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines.
Dohmoto K; Hojo S; Fujita J; Yang Y; Ueda Y; Bandoh S; Yamaji Y; Ohtsuki Y; Dobashi N; Ishida T; Takahara J
Int J Cancer; 2001 Feb; 91(4):468-73. PubMed ID: 11251967
[TBL] [Abstract][Full Text] [Related]
17. Quantitative correlation of cytokeratin 19 mRNA level in peripheral blood with disease stage and metastasis in breast cancer patients: potential prognostic implications.
Wong IH; Yeo W; Chan AT; Johnson PJ
Int J Oncol; 2001 Mar; 18(3):633-8. PubMed ID: 11179498
[TBL] [Abstract][Full Text] [Related]
18. Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.
Andergassen U; Hofmann S; Kölbl AC; Schindlbeck C; Neugebauer J; Hutter S; Engelstädter V; Ilmer M; Friese K; Jeschke U
Int J Mol Sci; 2013 Jan; 14(1):1093-104. PubMed ID: 23299436
[TBL] [Abstract][Full Text] [Related]
19. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
20. The Use of CYFRA 21-1 for the Detection of Breast Cancer Axillary Lymph Node Metastases in Needle Washouts of Fine-Needle Aspiration Biopsies.
Liscia DS; Detoma P; Zanchetta M; Anrò P; Molinar D; Favettini E; Paduos A
Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):190-195. PubMed ID: 26657871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
